HeraMED Limited (ASX:HMD)

December 4th

HeraBEAT users could be in line for full refunds on the cost of the product
HeraMED CEO David Groberman talks about the company’s progress

December 2nd 2019

HeraMED CEO David Groberman talks about the company’s progress
HeraMED continues to forge value adding partnerships

November 21st 2019

HeraMED continues to forge value adding partnerships
HeraMED receives FDA clearance for HeraBEAT

November 18th 2019

HeraMED receives FDA clearance for HeraBEAT
HeraMED’s new age technology addresses age-old problems

November 14th 2019

HeraMED’s new age technology addresses age-old problems
HeraMED secures initial order with major Brazilian health care group

February 14th 2019

HeraMED secures initial order with major Brazilian health care group
A New Number One – VUL Now Hold the Largest Lithium Resource in Europe

Subscribe to our weekly wrap.

Thanks for subscribing!

X